NVOUSDT

- %

Último precio

0,000000% / 00:00:00

Gráfico

Libro órdenes

Operaciones

Noticias

NVO/USDT Perpetual Futures

Último precio: 50.0700
Precio de referencia: --
Cambio en 24h: --
Máx. 24h: --
Mín. 24h: --
Vol. en 24h: --

Información - NVO

Capitalización de mercado: --
Suministro en circulación: --
Suministro total: --
Suministro máximo: --
Fecha de emisión: --

Introducción

Novo Nordisk holds approximately one-third of the global branded diabetes treatment market and is a world-leading provider of diabetes care products. Headquartered in Denmark, the company manufactures and markets a wide range of human and modern insulins, injectable diabetes treatments such as GLP-1 therapies, oral antidiabetic medications, and obesity treatments. Novo Nordisk also has a biopharmaceutical division (contributing less than 10% of revenue) specializing in protein therapies for hemophilia and other diseases.